Janux Therapeutics CEO David Campbell's 2021 pay jumps 936% to $8.4M
Janux Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Janux Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Janux Therapeutics received on average a compensation package of $5.6M, a 586% increase compared to previous year.
Average pay of disclosed executives at Janux Therapeutics
David Campbell, Chief Executive Officer, received $8.4M in total, which increased by 936% compared to 2020. 92% of Campbell's compensation, or $7.7M, was in option awards. Campbell also received $230K in non-equity incentive plan and $459K in salary.
Wayne Godfrey, Chief Medical Officer, received a compensation package of $4.3M. 92% of the compensation package, or $3.9M, was in option awards.
Shahram Salek-Ardakani, Chief Scientific Officer, earned $4M in 2021.
Related executives
You may also like
Source: SEC filing on April 29, 2022.